Home

Absurde Éclairer cette vas narasimhan décès Branche exiler

CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a  mistake he's determined to overcome | Fierce Pharma
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma

En un an, Vas Narasimhan a réinventé le laboratoire Novartis - Challenges
En un an, Vas Narasimhan a réinventé le laboratoire Novartis - Challenges

Novartis CEO says preparedness for a new pandemic has not improved
Novartis CEO says preparedness for a new pandemic has not improved

Vas Narasimhan | MCAAD
Vas Narasimhan | MCAAD

Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Novartis chief criticises EU move to control pharma licensing in emergencies
Novartis chief criticises EU move to control pharma licensing in emergencies

Vas Narasimhan on the post-pandemic world - Novartis Live. Magazine
Vas Narasimhan on the post-pandemic world - Novartis Live. Magazine

Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT

Bâle est très ouvert aux nouveaux arrivants - Basel Area Business &  Innovation
Bâle est très ouvert aux nouveaux arrivants - Basel Area Business & Innovation

Novartis se réorganise avec l'ambition de réduire ses coûts
Novartis se réorganise avec l'ambition de réduire ses coûts

Critiqué pour son salaire à 16 millions: Le CEO Vas Narasimhan se fait  atomiser à l'assemblée générale de Novartis
Critiqué pour son salaire à 16 millions: Le CEO Vas Narasimhan se fait atomiser à l'assemblée générale de Novartis

Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery |  Fortune
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune

30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images

The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED

30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images

How to get ordinary people to do extraordinary things: Novartis CEO Vas  Narasimhan on the multiplier
How to get ordinary people to do extraordinary things: Novartis CEO Vas Narasimhan on the multiplier

It was never my plan to be the boss of a huge company'
It was never my plan to be the boss of a huge company'

Vas Narasimhan (@VasNarasimhan) / X
Vas Narasimhan (@VasNarasimhan) / X

Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are  working to help more people get access to the medicines they need  #AccessinAction | Facebook
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook

Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT

Vas Narasimhan | Nature Reviews Drug Discovery
Vas Narasimhan | Nature Reviews Drug Discovery

The 'student' of leadership who seeks to inspire his employees
The 'student' of leadership who seeks to inspire his employees

Srishti Gupta with Vas Narasimhan
Srishti Gupta with Vas Narasimhan

Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D.,  Global Head of Drug Development and Chief Medical Officer, as the new CEO  of Novartis, effective February 1, 2018. We thank
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank

Vasant Narasimhan | Novartis
Vasant Narasimhan | Novartis

Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' -  The New York Times
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times

Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New  Technology
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology